<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">nnp</journal-id><journal-title-group><journal-title xml:lang="en">Neurology, Neuropsychiatry, Psychosomatics</journal-title><trans-title-group xml:lang="ru"><trans-title>Неврология, нейропсихиатрия, психосоматика</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2074-2711</issn><issn pub-type="epub">2310-1342</issn><publisher><publisher-name>"IMA-Press", LLC</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.14412/2074-2711-2009-61</article-id><article-id custom-type="elpub" pub-id-type="custom">nnp-360</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>PHARMACOTHERAPY</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ФАРМАКОТЕРАПИЯ</subject></subj-group></article-categories><title-group><article-title>COMPLEX THERAPY FOR HYPERTENSIVE AND MIXED ENCEPHALOPATHY</article-title><trans-title-group xml:lang="ru"><trans-title>Комплексная терапия гипертонической и смешанной энцефалопатии</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Румянцева</surname><given-names>С. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Rumyantseva</surname><given-names>S. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Москва</p></bio><bio xml:lang="en"><p>Moscow</p></bio><email xlink:type="simple">sofirum@yandex.ru</email><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>РГМУ</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Russian State Medical University</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2009</year></pub-date><pub-date pub-type="epub"><day>15</day><month>12</month><year>2009</year></pub-date><volume>1</volume><issue>3-4</issue><issue-title>NO3-4 (2009)</issue-title><fpage>81</fpage><lpage>86</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Rumyantseva S.A., 2009</copyright-statement><copyright-year>2009</copyright-year><copyright-holder xml:lang="ru">Румянцева С.А.</copyright-holder><copyright-holder xml:lang="en">Rumyantseva S.A.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://nnp.ima-press.net/nnp/article/view/360">https://nnp.ima-press.net/nnp/article/view/360</self-uri><abstract><p>Arterial hypertension (AH) is one of the main causes of the occurrence and progression of different types of vascular pathology. AH-associated functional and morphological impairments of the brain are the severe symptom complexes of hypertensive encephalopathy (HE), which require continuous correction. The measures for the prevention and treatment of all cardiovascular diseases, including HE, involve adequate correction of AH, correction of energy neuronal homeostatic disorders, as well as a harmonious combination of psychotherapeutic and pharmacological exposures.</p></abstract><trans-abstract xml:lang="ru"><p>Одной из главных причин возникновения и прогрессирования разных видов сосудистой патологии является артериальная гипертензия (АГ). Связанные с ней функциональные и морфологические нарушения состояния вещества головного мозга проявляются тяжелыми симптомокомплексами гипертонической энцефалопатии (ГЭ), которые требуют постоянной коррекции. Меры для профилактики и лечения всех сердечно-сосудистых заболеваний, в том числе ГЭ, включают адекватную коррекцию АГ, расстройств энергетического нейронального гомеостаза, а также гармоничное сочетание психотерапевтического и фармакологического воздействия.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>артериальная гипертензия</kwd><kwd>гипертоническая энцефалопатия</kwd><kwd>астения</kwd><kwd>коррекция</kwd><kwd>актовегин</kwd></kwd-group><kwd-group xml:lang="en"><kwd>hypertensive encephalopathy</kwd><kwd>asthenia</kwd><kwd>correction</kwd><kwd>actovegin</kwd><kwd>arterial hypertenstion</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
